The global ANA Test market is anticipated to grow at a considerable CAGR of 12.3% during the forecast period. The increasing approvals for the various advanced treatments by the FDA and other organizations are contributing to the growth of the global market. For instance, in January 2022, Paracrine, Inc. announced that the FDA has granted full approval of its Investigational Device Exemption (IDE) to conduct a pivotal trial titled Scleroderma Treatment with Celution Processed Adipose-Derived Regenerative Cells: A Randomized, Double-blind, and Placebo-Controlled Study - the “STAR II Trial.”

The global wearable sensors market is anticipated to grow at a CAGR of 9.1% during the forecast period. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in In July 2020, analog devices inc acquired the high definition multimedia interface business of INVECAS. The acquisition will enhance ADI's audio and video solutions portfolio and will meet the grwoun4needs of enterprise and consumer markets.

The global video analytics market is anticipated to grow at an exponential CAGR of 24.7% during the forecast period (2022-2028). The on-premises video analytics industry is anticipated to hold the highest market share during the forecast period. The attributable factor for the growth of the segment is the fact that this solution is being used by large organizations with a large number of cameras that are generating tons of gigabytes (GB) of footage daily. This will be altogether several terabytes (TB) of data collection.  Sending such a large amount of data to the cloud for processing will be overwhelming and there will be bottlenecks of network bandwidth causing a high latency rate, which is not ideal for security. 

The global tissue diagnostics market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2022-2028). Tissues are used to diagnose and classify diseases. They are used to identify if a patient has cancer as well as what kind of cancer and the characteristics of cancer. Additionally, tissue diagnostics capture the disease insights and the parameters that factor into the patient outcomes. The major factor driving the growth of the global tissue diagnostics market during the forecast period is the increasing healthcare expenditure across the globe.

The global tissue diagnostics market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2022-2028). Tissues are used to diagnose and classify diseases. They are used to identify if a patient has cancer as well as what kind of cancer and the characteristics of cancer. Additionally, tissue diagnostics capture the disease insights and the parameters that factor into the patient outcomes. The major factor driving the growth of the global tissue diagnostics market during the forecast period is the increasing healthcare expenditure across the globe.

The global sodium-ion battery market is anticipated to grow at a considerable CAGR of 7.9% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth. Hence owing to the development and manufacturing of innovative solutions the sodium-ion battery market is augmenting its growth over the forecast period. For instance, in January 2022, Bluetti introduced the sodium-ion solar generator NA300 sodium-ion generator along with the sodium-ion B480 battery pack to power the generator. The NA300 is being touted as the fastest charging solar generator which can go from 0-80% in just 30 minutes.

The global smart syringe market is anticipated to grow at a significant CAGR of 10.3% during the forecast period. The key companies across the globe are highly inclined toward the adoption of different growth strategies including capacity expansion, partnerships, government initiatives, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. 

The global smart grid market is anticipated to grow at an exponential CAGR of 20.0% during the forecast period (2022-2028). A smart grid is used to develop the electrical power grid to handle a large amount of electricity production such as solar and wind energy. Smart grids are a better alternative to the traditional methods of electrical networks to cater to the increased needs in terms of accessibility, flexibility, reliability, and quality of power supply. 

The global smart electric meter market is anticipated to grow at a considerable CAGR of 7.6% during the forecast period (2022-2028). Smart meters offer various advantages, such as theft detection further raising the demand for smart meters across the globe. The smart meters provide theft and accurate billing and enhanced customer services through the integration of AMI systems. Along with that, the growth is attributed to the increasing penetration of smart meters in the near future, owing to government regulation and initiatives, rising demand for utility management, and rising urbanization in emerging economies such as India and China. For instance, in November 2021, the European Union announced to launch of three new smart grid projects including Carpathian Modernized Energy Network (CARMEN) project, the Gabreta project, and Green Switch. 

The global liquid biopsy market is anticipated to grow at a significant CAGR of 17.3% during the forecast period (2022-2028). The liquid biopsy diagnosis has been driven by several factors, and one of them is the advantages it offers over the other process. Liquid biopsy is a process that requires body liquid. There are several body fluids that contain genetic material derived from tumors such as urine, saliva, stool, blood, and cerebrospinal fluid (CSF).